| Literature DB >> 30233769 |
Behjat Kalantari-Khandani1, Ali Akbar Haghdoost2, Mohsen Momeni3, Mina Danaei4.
Abstract
The co-occurrence of different types of hemo-lymphopoietic malignancies within a family provides clues about the pattern of inheritance and common environmental risk factors. A family presented with developing hemo-lymphopoietic cancers in three female first-degree relatives: a mother and her daughters. Case 1 was diagnosed with Walden Strom's macroglobulinemia at age 57. Case 2 and 3 presented with chronic myelogenous leukemia at age 32 and diffuse large B-cell lymphoma at age 28, respectively. There were not any significant common environmental risk factors in this family, but all three cases suffered from skin dermatitis and one of them, who suffered from chronic myelogenous leukemia, was diagnosed with morphea. This family had a sedentary and stressful lifestyle. Genetic is the foundation of some familial aggregation of cancers. Common lifestyle habits and environmental etiologies are important. Morphea as an autoimmune disease could have the essential role in developing hematolymphoid malignancies.Entities:
Keywords: Leukemia; Lymphoma; Neoplasms; Risk factors
Year: 2018 PMID: 30233769 PMCID: PMC6141424
Source DB: PubMed Journal: Int J Hematol Oncol Stem Cell Res ISSN: 2008-2207
Descriptive characteristics of three cases
|
|
|
|
| |||
|---|---|---|---|---|---|---|
|
|
|
|
|
| ||
| 57 | Housewife | -Weakness | WM | -Consuming solid oils | -Having middle | Dermatitis and |
| 32 | Housewife | -Fatigue | CML | -Consuming solid oils | -Having middle | Morphea |
| 28 | Housewife | -Fever | DLBCL | -Consuming solid oils | -Having middle | Infertility |
Walden Strom's macroglobulinemia,
Chronic myelogenous leukemia,
Diffuse large B-cell lymphoma
Description of population-based studies about the familial risk for Hemolymphopoietic malignancies
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
| ||||||
| Kristinsson, S. Y | 2008 | LPL/WM | 3(2-4.4) | 0.8(0.3-2.2) | 3.4(1.7-6.6) | - |
| Paltiel, O | 2000 | LPL | 1.7(0.9-2.9) | 1.2(0.4-2.5) | 1.1(0.4-2.3) | 1.4(0.9-1.9) |
| Paltiel, O | 2000 | NHL/HL | 1.7(0.9-2.9) | 1.2(0.4-2.5) | - | - |
: Relative Risk,
: Only CLL,
SIR
Description of case-control studies about the risk of NHL or HL by family history of NHL, HL, Leukemia and hematopoietic cancers
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
| |||||||
| Wang,S.S | 10211 cases& | 2007 | NHL | 1.5 | 1.6 | 1.4 (1.2-2.7) | 1.4 (1.2-1.6) |
| Mensah, FK | 699cases& | 2007 | NHL | - | - | 1.4 0.8-2.6) | 1.7 (1.1-2.7) |
| Negri,E | 225cases& 504 | 2006 | NHL | 1.8 | - | 2 (0.6-5.9) | 3 (1.2-7) |
| Casey, R | 2480cases& | 2006 | LN | - | 3.4 | 1.5 (1.1-2.1) | 1.6 (1.2-2.1) |
| Chang, E.T | 1506 cases&1229 | 2005 | NHL | 2.2 | 0.4 | 3.2 (1.2-8.8) | 1.8 (1.2-2.5) |
| Chang, E.T | 1506 cases&1229 | 2005 | HL | 3.3 | 3.3 | 6.3 (1.3-9.9) | 2.1 (1-4.3) |
| Chatterjee, N | 1321cases& | 2004 | NHL | 2.06 | 1.6 | 1.1 (0.6-2.1) | 1.2 (0.8-1.8) |
| Goldin, L.R | 5047cases& | 2004 | HL | 1.26 | 3.11 | 2.11 (1.18-.8) | 1.65 (1.3-2.1) |
: Only CLL